Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
04/04DJNew Rules on Tax Inversions Threaten Pfizer-Allergan Deal
04/01DJPFIZER : Cholesterol Drug Meets Co-Primary Endpoints in Latest Study
03/31 U.S. FTC sues Endo alleging antitrust violations
03/31DJFTC Accuses Endo of Paying Off Generic Drugmakers
03/30DJFTC Seeks More Information on Pfizer-Allergan Merger
03/30DJPFIZER : FTC Seeks More Information on Pfizer-Allergan Merger
03/29DJSHIRE : Wins US Patent Trial for Bowel Disease Drug
03/21 TIMELINE : Shakeup at Valeant as longtime CEO Pearson leaving
03/18DJPFIZER : Sanders Urges New Tax Rules On Inversion Deals
03/18DJValeant Rout Vindicates Allergan Directors
03/17DJGlaxo CEO Andrew Witty to Retire
03/16DJWILLIAM ACKMAN : Bill Ackman Sheds Assets, as Pershing Portfolio Sinks
03/15DJPfizer CEO's 2015 Total Pay Valued at $18 Million
03/15DJIAN READ : Pfizer CEO Read's 2015 Total Pay Valued at $18 Million
03/15 TIMELINE : More trouble for Valeant as possible debt default looms
03/15DJTEVA PHARMACEUTICAL : Acquisition of Allergan Generics Unit Delayed--Update
03/15DJTeva Acquisition of Allergan Generics Unit Delayed
03/15DJTEVA PHARMACEUTICAL : Acquisition of Allergan Generics Unit Delayed
03/15 Teva Pharm sees close of $40.5 billion Allergan generics deal by June
03/10DJTEVA PHARMACEUTICAL : EU Approves Teva Takeover of Allergan Generics Unit -- Upd..
03/10DJEU Approves Teva Takeover of Allergan Generics Unit
03/10DJTEVA PHARMACEUTICAL : EU Approves Teva's Takeover of Allergan's Generics Unit
03/10 EU approves Teva bid for Allergan's generics with conditions
03/10 EXCLUSIVE - TEVA SET TO WIN EU OKAY : sources
03/09DJTeva Deal for Allergan Generics Unit Expected to Get Europe OK -Reuters
03/08DJValeant in Talks to Add New Board Members
02/29DJValeant CEO Michael Pearson Returns From Medical Leave
02/22 Allergan's revenue beats on higher U.S. brand sales
02/22DJALLERGAN : Tops Expectations on Botox Sales -- Update
02/22DJAllergan Tops Expectations on Botox Sales
02/19 Teva offers EU concessions over Allergan generics deal
02/17 GEORGE SOROS : filing
02/12DJLILLY : U.K. Court Rules in Opponent's Favor on Alimta Patent
02/12DJELI LILLY : Lilly : U.K. Court Rules in Opponent's Favor on Alimta Patent
02/12 Eli Lilly loses latest round in UK drug patent battle
02/11DJTeva Pharmaceuticals Reports Sales Decline
02/11DJTEVA PHARMACEUTICALS : Reports Sales Decline
02/08DJPFIZER : Outlines Post-Merger Management Slate
02/08DJPFIZER : Outlines Post-Allergan Merger Management Slate
02/08 Pfizer unveils management line up for combined company
02/02 Pfizer 2016 forecast disappoints
02/02DJPFIZER : Beats Expectations but Guidance Disappoints
02/02 Pfizer forecasts 2016 revenue, earnings below estimates
01/26 J&J profit beats forecasts, helped by lower taxes, cost cuts
01/26 Johnson Controls to buy Ireland-based Tyco for $16.5 billion
01/26 Johnson Controls to buy Ireland-based Tyco for $16.5 billion
01/25DJTyco, Johnson Controls Bet Bigger Is Better
01/14 PFIZER WEIGHING SALE OF HOSPIRA'S PU : Bloomberg
01/13 Pfizer, Allergan say combined drug pipeline 'underappreciated'
01/11DJDrugmakers Keep Raising Prices Despite Criticisms
01/08DJPFIZER : Seeks To Invest In More Early Stage Research Companies
01/08 Pfizer hikes U.S. prices for over 100 drugs on January 1
01/07DJALLERGAN : Inks $90 Million Deal for Anterios
2015DJCelgene Reaches Settlement in Revlimid Patent Dispute
2015DJCF, OCI Amend Merger Agreement to Keep 'Inversion' Tax Benefit
2015DJBarclays to Create Two New M&A Teams
2015 Dow, DuPont eye big tax savings in rare merger of equals
2015DJPFIZER : Raises Quarterly Dividend by 7.1%
2015 MORGAN STANLEY NAMES COLLINS TO GLOB : memo
2015DJ2015 Becomes the Biggest M&A Year Ever
2015 TEVA DIVESTING $1 BILLION IN ASSETS : sources
2015 MORGAN STANLEY NAMES COLLINS TO GLOB : memo
2015 JPMorgan tops investment banking revenue table, helped by M&A - survey
2015 Two-decade Pfizer mission pays off for Guggenheim's deal king
2015DJPFIZER : Correction to Barron's Friday Blog Item on Pfizer-Allergan
2015DJPFIZER : Lyrica Fails to Treat Traumatic Neuropathic Pain
2015DJPFIZER : Lyrica Fails to Treat Traumatic Neuropathic Pain
2015DJPFIZER : Is Pfizer's Deal Good For Ireland?
2015DJSkadden's Tax Work Anything But Dull
2015DJPFIZER : Allergan Deal Offers Ireland Few New Benefits
2015 Germany's Schaeuble says need to ensure tax base doesn't erode
2015DJPFIZER : With Merger Looming, Pfizer Weighs Plan To Split In Two
2015 U.S. politicians slam tax-avoiding Pfizer-Allergan deal
2015DJPFIZER : and Allergan Strike $155 Billion Inversion Deal--7th Update
2015 Pfizer to buy Allergan in $160 billion deal
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 16 714 M
EBIT 2016 7 814 M
Net income 2016 -193 M
Debt 2016 14 520 M
Yield 2016 -
P/E ratio 2016 602,35
P/E ratio 2017 96,24
EV / Sales 2016 6,76x
EV / Sales 2017 5,90x
Capitalization 98 474 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 293 $
Spread / Average Target 18%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Brenton L. Saunders President, Chief Executive Officer & Director
Paul M. Bisaro Executive Chairman
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC98 474
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results